Skip to content

CareTrust CTRE Foreign currency translation gains (losses)

Foreign currency translation gains (losses) at other companies

Repligen logo
RepligenRGEN
-$11.67M-349%
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
$1.78M+89,300%
Mercury Systems logo
Mercury SystemsMRCY
$7.24M+2,927%
EOG Resources logo
EOG ResourcesEOG
$1M
Lineage, Inc. logo
Lineage, Inc.LINE
-$33M-152%
Armstrong World Industries logo
Armstrong World IndustriesAWI
-$700K-333%

Other financials

Income statement

See full
Revenue$142.8M+47.8%
Gross profit$49.7M
Net income$80.2M+21.9%
EPS (diluted)$0.36+2.9%

Balance sheet

See full
Cash & equivalents$223.2M-64.7%
Total debt$894.6M+8.8%
Total equity$4.1B+41.1%
Total assets$5.2B+34.8%

Cash flow

See full
Operating cash flow$90.4M+26.6%
CapEx$440.3K
Free cash flow$98.1M+60.6%

Valuation

See full
Market cap$8.76B+52.5%
Enterprise value$9.43B+59.4%
P/E26.1×-9.3×
P/S16.8×-0.6×

Profitability

See full
Gross margin100%
Net margin64.1%+14.9pp
FCF margin82.3%-0.1pp

Returns & leverage

See full
Return on equity9.5%+2.4pp
Debt / equity0.2×-0.1×

Where this comes from

Reported directly by CareTrust in its filing.

Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax.

The official record: CareTrust’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about CareTrust's foreign currency translation gains (losses).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CareTrust's foreign currency translation gains (losses)?
CareTrust (CTRE) reported foreign currency translation gains (losses) of -$18.38M in Q1 2026.
What does foreign currency translation gains (losses) mean?
This represents the gains or losses resulting from the translation of financial statements of foreign subsidiaries from their functional currency into the reporting currency. These amounts are recorded in equity rather than the income statement.